The Blue Jet Healthcare date has been confirmed from October 25 and ended on October 27 .
The bidding for the Blue Jet Healthcare IPO commenced on October 25, 2023 and concluded on October 27, 2023. The allotment process for the Blue Jet Healthcare IPO was finalized on Monday, October 30, 2023. Subsequently, the shares were listed on both the BSE and NSE on November 1, 2023.
Start your investing journey today. How do you open your own demat account for free?
Bidding Dates
October 25 – 27 ,2023
Price Range
₹329 to ₹346 per share
Face Value
₹2 per share
GMP
₹-2
Blue Jet Healthcare GMP
The Blue Jet Healthcare IPO GMP is ₹[-2].
IPO Overview
Blue Jet Healthcare is a manufacturer of pharmaceutical and healthcare ingredients and intermediates. They provide specialty items to innovator pharmaceutical firms as well as multi-national generic pharmaceutical corporations. Their business is divided into three product groups: (i) contrast media intermediates, (ii) high-intensity sweeteners, and (iii) pharma intermediates and active pharmaceutical ingredients (“APIs”). They served more than 350 consumers in 35 countries over the last three fiscal years. They have established long-term relationships with
The price range for the Blue Jet Healthcare IPO has been established at ₹329 to ₹346 per share. Retail investors are required to invest a minimum amount of ₹14,878 and the minimum lot size for their application is 43 shares. As for sNII, the minimum lot size investment is 14 lots (602 shares), totaling ₹208,292. On the other hand, bNII has a minimum lot size investment of 68 lots (2,924 shares), amounting to ₹1,011,704.
Blue Jet Healthcare IPO Date & Price Band Details
| IPO Date | October 25, 2023 to October 27, 2023 |
| Listing Date | November 1, 2023 |
| Face Value | ₹2 per share |
| Price Band | ₹329 to ₹346 per share |
| Lot Size | 43 Shares |
| Total Issue Size | 24,285,160 shares (aggregating up to ₹840.27 Cr) |
| Offer for Sale | 24,285,160 shares of ₹2 (aggregating up to ₹840.27 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 173,465,425 |
| Share holding post issue | 173,465,425 |
Blue Jet Healthcare IPO Market Lot
| Application | Lot | Shares | Amount |
| Retail (Min) | 1 | 43 | ₹14,878 |
| Retail (Max) | 13 | 559 | ₹193,414 |
| S-HNI (Min) | 14 | 602 | ₹208,292 |
| S-HNI (Max) | 67 | 2,881 | ₹996,826 |
| B-HNI (Min) | 68 | 2,924 | ₹1,011,704 |
Blue Jet Healthcare IPO Allotment and Listing Dates
| Price Band Announcement: | 2023 |
| Anchor Investors Allotment: | 2023 |
| IPO Open Date: | 2023 |
| IPO Close Date: | 2023 |
| Basis of Allotment: | 2023 |
| Refunds: | 2023 |
| Credit to Demat Account: | 2023 |
| IPO Listing Date: | 2023 |
Blue Jet Healthcare IPO Reservation
| Investor Category | Shares Offered | Maximum Allottees |
| Anchor Investor Shares Offered | 7,285,548 (30.00%) | NA |
| QIB Shares Offered | 4,857,032 (20.00%) | NA |
| NII (HNI) Shares Offered | 3,642,774 (15.00%) | |
| bNII > ₹10L | 2,428,516 (10.00%) | 4,034 |
| sNII < ₹10L | 1,214,258 (5.00%) | 2,017 |
| Retail Shares Offered | 8,499,806 (35.00%) | 197,669 |
| Total Shares Offered | 24,285,160 (100%) | NA |
Blue Jet Healthcare IPO EPS
| Year | EPS Growth in (Rs.) | Return on Net Worth% |
| 2022 | ₹10.47 | 34.82 |
| 2021 | ₹7.98 | 39.96 |
| 2020 | ₹8.35 | 71.97 |
Blue Jet Healthcare IPO Dates
| Open Date : | October 25, 2023 |
| Close Date : | October 27, 2023 |
| Allotment Date : | Monday, October 30, 2023 |
| Refund Date : | Tuesday, October 31, 2023 |
| Share Credit Date : | Tuesday, October 31, 2023 |
| Listing Date : | Wednesday, November 1, 2023 |
Blue Jet Healthcare Company Financial Report Blue Jet
| ₹ in Crores | Revenue | Expense | PAT |
| Year | Revenue | Expense | PAT |
| 2020 | ₹544 | ₹345 | ₹145 |
| 2021 | ₹508 | ₹318 | ₹136 |
| 2022 | ₹703 | ₹460 | ₹182 |
| 2023 | ₹745 | ₹TBA | ₹160 |
Healthcare IPO Valuation – FY2022
Check Blue Jet Healthcare IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| Earning Per Share (EPS): | ₹10.47 per Equity Share |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 34.82% |
| Net Asset Value (NAV): | ₹30.07 per Equity Share |
Company Profile
Blue Jet Healthcare is a manufacturer of pharmaceutical and healthcare ingredients and intermediates. They provide specialty items to innovator pharmaceutical firms as well as multi-national generic pharmaceutical corporations. Their business is divided into three product groups: (i) contrast media intermediates, (ii) high-intensity sweeteners, and (iii) pharma intermediates and active pharmaceutical ingredients (“APIs”). They served more than 350 consumers in 35 countries over the last three fiscal years. They have established long-term relationships with
innovator pharmaceutical firms as well as multi-national generic pharmaceutical companies, which are supported by multi-year contracts. Their product capabilities in the pharmaceutical and healthcare sectors have expanded to meet the needs of their clients, aided by manufacturing capabilities and technology-driven product development.
Registrar Info
| Name | LINK INTIME INDIA PRIVATE LIMITED |
| Phone number | 04067162222, 04079611000 |
| Email ID | bluejet.ipo@linkintime.co.in |
| Website | https://www.linkintime.co.in |
Contact Details
| Name | Cello World LIMITED |
| Phone number | +91 (22) 4184 0550 |
| Email ID | companysecretary@bluejethealthcare.com |
| Website | https://www.bluejethealthcare.com |
IPO Strenghts
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.
